Brandon A Berryhill
Overview
Explore the profile of Brandon A Berryhill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ismail A, Berryhill B, Gil-Gil T, Manuel J, Smith A, Baquero F, et al.
Microbiol Spectr
. 2025 Mar;
:e0247924.
PMID: 40035534
Importance: Much of the research on antibiotics and antibiotic treatment has focused on drug concentrations sufficient to prevent the growth of bacteria. These concentrations, however, are not always reached everywhere...
2.
Levin B, Gil-Gil T, Berryhill B, Woodworth M
bioRxiv
. 2025 Feb;
PMID: 39990355
With the increase in the placement of prosthetic joints and other hardware in the body has come an increase in associated infections. These infections are particularly difficult to treat due...
3.
Gil-Gil T, Berryhill B
bioRxiv
. 2024 Sep;
PMID: 39282318
Synopsis: Background: There is a long-standing belief that bacteriostatic drugs are inherently antagonistic to the action of bactericidal antibiotics. This belief is primarily due to the fact that the action...
4.
Gil-Gil T, Berryhill B, Manuel J, Smith A, McCall I, Baquero F, et al.
Nat Commun
. 2024 Sep;
15(1):7936.
PMID: 39261449
Traditionally, bacteriostatic antibiotics are agents able to arrest bacterial growth. Despite being traditionally viewed as unable to kill bacterial cells, when they are used clinically the outcome of these drugs...
5.
Berryhill B, Gil-Gil T, Witzany C, Goldberg D, Vega N, Regoes R, et al.
bioRxiv
. 2024 Sep;
PMID: 39229007
Critical to our understanding of infections and their treatment is the role the innate immune system plays in controlling bacterial pathogens. Nevertheless, many in vivo systems are made or modified...
6.
Berryhill B, Burke K, Smith A, Morgan J, Tarabay J, Mamora J, et al.
Infect Control Hosp Epidemiol
. 2024 May;
:1-7.
PMID: 38706211
Objective: To determine if the high-level personal protective equipment used in the treatment of high-consequence infectious diseases is effective at stopping the spread of pathogens to healthcare personnel (HCP) while...
7.
Ismail A, Berryhill B, Gil-Gil T, Manuel J, Smith A, Baquero F, et al.
bioRxiv
. 2024 Apr;
PMID: 38617265
The rational design of the antibiotic treatment of bacterial infections employs these drugs to reach concentrations that exceed the minimum needed to prevent the replication of the target bacteria. However,...
8.
Levin B, Berryhill B, Gil-Gil T, Manuel J, Smith A, Choby J, et al.
Proc Natl Acad Sci U S A
. 2024 Apr;
121(16):e2318600121.
PMID: 38588431
Antibiotics are considered one of the most important contributions to clinical medicine in the last century. Due to the use and overuse of these drugs, there have been increasing frequencies...
9.
Banh D, Roberts C, Morales-Amador A, Berryhill B, Chaudhry W, Levin B, et al.
Nature
. 2023 Dec;
625(7993):E3.
PMID: 38052939
No abstract available.
10.
Mumma J, Weaver B, Morgan J, Ghassemian G, Gannon P, Burke K, et al.
BMJ Qual Saf
. 2023 Dec;
33(7):419-431.
PMID: 38050151
Background: Relatively little is known about the cognitive processes of healthcare workers that mediate between performance-shaping factors (eg, workload, time pressure) and adherence to infection prevention and control (IPC) practices....